Wilson Sonsini Goodrich & Rosati advised SR One Capital Management on the deal.ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA targeting therapeutics, announced the completion of…
ADARx’s $75 Million Series B Financing


Wilson Sonsini Goodrich & Rosati advised SR One Capital Management on the deal.ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA targeting therapeutics, announced the completion of…
…